A study to evaluate the effectivity of Portable Ultrasound Device in differentiating benign and malignant disease in patients with palpable breast lump
Not Applicable
- Conditions
- Health Condition 1: C509- Malignant neoplasm of breast of unspecified site
- Registration Number
- CTRI/2023/03/050522
- Lead Sponsor
- International Agency for Research on Cancer (World Health Organization)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Women positive on CLinical Breast Examination
Exclusion Criteria
Women with debilitating illness
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate the agreement between PUD and mammography /ultrasound by a radiologist in differentiating malignant and benign solid breast lesionsTimepoint: Recruitment of women: 18 months, <br/ ><br>Outcome data assessment and analysis: at the end of 18 months.
- Secondary Outcome Measures
Name Time Method To collect annotated images of breast ultrasound for future development of artificial algorithm in breast cancer detectionTimepoint: Recruitment of women: 18 months, <br/ ><br>Outcome data assessment and analysis: at the end of 18 months.;To develop a diagnostic algorithm that incorporates PUD in the triage of breast lumps detected on CBE to avoid unnecessary imaging and biopsy procedures for benign lumpsTimepoint: Recruitment of women: 18 months, <br/ ><br>Outcome data assessment and analysis: at the end of 18 months.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms distinguish benign from malignant breast lesions using portable ultrasound imaging?
How does portable ultrasound compare to mammography in triaging palpable breast lumps in low-resource settings?
Which biomarkers correlate with ultrasound imaging features in C509 breast cancer subtypes?
What adverse events are associated with portable ultrasound-based breast cancer diagnostics?
Are there combination diagnostic approaches integrating portable ultrasound with liquid biopsy markers for breast cancer?